 NORCROSS, Ga., May 23, 2022 GLOBE NEWSWIRE -- Galectin Therapeutics Inc. NASDAQ: GALT, the leading developer of therapeutics that target galectin proteins, announced today the Company will be presenting at the H.C. Wainwright Global Investment Conference being held from May 23-26, 2022 and at the 5th Global NASH Congress in London, UK on May 26-27, 2022. 